Orion Biotech Opportunities Corp. (ORIAU) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$20M$20M$15M$15M$10M$10M$5M$5M$0$0-$5M-$5MEarning20212021202220225%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

ORIAU Income statement / Annual

Last year (2022), Orion Biotech Opportunities Corp.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2022, Orion Biotech Opportunities Corp.'s net income was $18.41 M. See Orion Biotech Opportunities Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021
Period Ended 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00
Cost of Revenue $0.00 $0.00
Gross Profit $0.00 $0.00
Gross Profit Ratio 0 0
Research and Development Expenses $0.00 $0.00
General & Administrative Expenses $899.67 K $553.69 K
Selling & Marketing Expenses $0.00 $0.00
Selling, General & Administrative Expenses $899.67 K $553.69 K
Other Expenses $0.00 $0.00
Operating Expenses $899.67 K $553.69 K
Cost And Expenses $899.67 K $553.69 K
Interest Income $0.00 $0.00
Interest Expense $0.00 $96.29 K
Depreciation & Amortization $0.00 -$96.29 K
EBITDA -$10.56 M -$724.00 K
EBITDA Ratio 0 0
Operating Income Ratio 0 0
Total Other Income/Expenses Net $9.66 M -$96.29 K
Income Before Tax $8.76 M -$724.00 K
Income Before Tax Ratio 0 0
Income Tax Expense -$9.66 M $96.29 K
Net Income $18.41 M -$821.00 K
Net Income Ratio 0 0
EPS 0.92 -0.0328
EPS Diluted 0.92 -0.0328
Weighted Average Shares Out $20.00 M $18.79 M
Weighted Average Shares Out Diluted $20.00 M $18.79 M
Link